ArticleBMC nephrology2023

Glomerular proteomic profiling reveals early differences between preexisting and de novo type 2 diabetes in human renal allografts.

Anne Kipp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.